Cabaletta Bio, Inc.

CABA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$116-$68-$53-$46
Dep. & Amort.$2$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$19$11$7$6
Change in WC$2$0-$4$6
Other Non-Cash$5$1$3$0
Operating Cash Flow-$88-$54-$46-$34
Investing Activities
PP&E Inv.-$2-$1-$2-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$84-$50$0
Inv. Sales/Matur.$50$63$25$7
Other Inv. Act.$0$0-$0$0
Investing Cash Flow$47-$22-$27$6
Financing Activities
Debt Repay.-$1$0$0$0
Stock Issued$11$185$33$48
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$2$2$0$1
Financing Cash Flow$12$188$33$49
Forex Effect-$0$0$0$0
Net Chg. in Cash-$29$112-$41$21
Supplemental Information
Beg. Cash$193$82$122$101
End Cash$164$193$82$122
Free Cash Flow-$90-$54-$49-$35
Cabaletta Bio, Inc. (CABA) Financial Statements & Key Stats | AlphaPilot